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Liver mRNA levels of two acute phase reactant (APR) proteins, %-HS glycoprotein (a major negative APR) and q-acid glycoprotein (a major 
positive APR) were measured in male rats at different times after the administration of turpentine, of tumor necrosis factor, or following partial 
hepatectomy. In every case, a marked decrease in mRNA levels of a;-HS glycoprotein was observed which reached a maximum at 24 h. A concomi- 
tant increase of q-acid glycoprotein mRNA levels was observed under the same conditions. These results indicate that the decreasedlevels of d;-HS 
glycoprotein induced by the acute-phase response following inflammatory mediators and partial hepatectomy are due to a down-regulation of the 
gene expression of this protein in rat liver. 
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1. INTRODUCTION 
arz-HS glycoprotein (AHSG) is a human plasma 
glycoprotein synthesized by the liver [l]. It has been 
shown to be involved in a number of functions such as 
opsonization [2], endocytosis [3], brain development 
[4], and formation of bone tissue [5]. Nevertheless, its 
precise biological role is still unknown. The human pro- 
tein consists of two subunits, an A chain of 282 amino 
acids [6] and a B chain of 27 amino acids [7]. In- 
terestingly, the corresponding cDNA sequence showed 
the A and B chains to be encoded by a single mRNA 
transcript [8]. 
Plasma concentrations of AHSG fall significantly 
following trauma [9] and during inflammatory response 
[lo], and this protein is considered as the example of the 
so-called ‘negative acute phase reactants’. In vitro we 
have shown that the synthesis of AHSG in liver cells 
was down-regulated by inflammatory mediators pro- 
duced by activated monocytes, including IL-6 and IL-l 
[ll]. We have further shown that, in this in vitro 
system, the rate of synthesis of AHSG was closely cor- 
related with the changes in its corresponding mRNA 
levels [ 111. AHSG mRNA transcripts are found not on- 
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ly in human hepatoma cell lines, but also in rat liver [8], 
although the corresponding protein in the rat has not 
been completely characterized. 
In the present study, we have examined the changes in 
the mRNA levels for AHSG in adult rat liver in 
response to in vivo acute inflammation, injection of 
tumor necrosis factor or partial hepatectomy, and com- 
pared them to those of cui-acid glycoprotein (ORM), a 
typical ‘positive’ acute phase reactant. 
2. MATERIALS AND METHODS 
2.1. Animals 
Male Sprague-Dawley adult rats (weight 180-200 g), purchased 
from Charles River (France), were maintained on a 12 h light/l2 h 
dark cycle, with a standard laboratory chow, and water available ad 
libitum. 
The effect of TNF was studied by injecting subcutaneously 20 cg of 
recombinant murine TNF (spec. act. 1.6x 10’ U/mg, kindly provided 
by Dr W. Fiers, Ghent, Belgium). Acute inflammation was induced 
by a single subcutaneous injection of 10 ml turpentine oil/kg body 
weight in the lumbar region. Partial hepatectomy was performed be- 
tween 10.00 and 13.00 h according to the technique described by Hig- 
gins and Anderson [12], removing an average 75% of the liver. Liver 
mRNA analyses were performed after removal of the livers under 
ether anesthesia at different times following TNF injection, ex- 
perimental inflammation, or partial hepatectomy. 
2.2. cDNA probes 
A plasmid containing an at-acid glycoprotein (ORM) cDNA insert 
was a generous gift of Dr Taylor (Gladstone Foundation Laboratory, 
San Francisco) and CYI-HS glycoprotein (AHSG) cDNA was obtained 
as described [13]. The two purified cDNA inserts (25-50 pg) were 
radiolabeled with [o-‘2P]dCTP, using the random primer technique 
developed by Feinberg and Vogelstein [14]. 
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Fig. 1. Northern blot analysis of rat liver RNA extracted at 0, 12, 24, 48 and 72 h after turpentine injection. 50 fig aliquots of total liver RNA 
were separated on denaturing agarose gels. The RNAs were blotted onto nitrocellulose and hybridized with “P-labeled cDNA probes corresponding 
respectively to AHSG and ORM. 
2.3. RNA preparation 
Livers were homogenized in 4 M guanidium thiocyanate and RNAs 
were isolated by centrifugation through a 5.7 M CsCl layer as describ- 
ed [IS]. RNA concentrations were determined by measuring the ab- 
sorbance at 260 nm. The integrity of RNA preparations was con- 
trolled by agarose lectrophoresis and visualization of the 18 S and 28 
S ribosomal RNA bands after ethidium bromide staining. 
2.4. Northern, blot analysis 
Samples of total RNA were denatured for 15 min at 55°C in 10 mM 
sodium phosphate buffer, pH 7.0 containing 2.2 M formaldehyde and 
50% formamide, then applied to 1.2% agarose gels containing 2.2 M 
formaldehyde and separated by electrophoresis at 70 V for 4 h. 
Transfer was performed for at least 12 h onto Hybond nylon filters 
in 20 x SSC [16]. The filters were baked and hybridized. Hybridiza- 
tion was performed at 42°C overnight and filters were washed under 
medium stringency conditions (6 x SSC at room temperature for 4 x 5 
min, then 2 x 15 min in 2 x SSC, 1% SDS at 65°C). In some cases, 
after autoradiography, hybridization bands were quantified by den- 
sitometric scanning. 
3. RESULTS 
3.1. Effect of experimental inflammation on the levels 
of cy2-HS glycoprotein and al-acid glycoprotein 
mRNAs 
We have compared the time course variations of 
AHSG mRNA in liver cells of adult male Sprague- 
Dawley rats after subcutaneous injection of turpentine. 
Fig. 1 shows that the decrease of the AHSG mRNA 
levels, as evidenced by Northern blotting, was obvious 
at 12 h and was maximum at 24 h. Thereafter, the levels 
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Fig. 2. Time course analysis of the effect of TNF injection (20 Fg) on 
the expression of the AHSG and ORM genes. Northern blot analysis 
of 40 pg aliquots of total liver RNA extracted at 0, 12 and 24 h was 
performed as described in Fig. 1. 
80 
of AHSG mRNA increased to come back to normal at 
72 h. As a control, similar mRNA blots were hybridized 
with a cDNA probe for ORM, known as being a strong 
positive acute phase protein in man and in rats [17]. 
Results (Fig. 1) show that ORM mRNA levels were 
dramatically increased at 12 and 48 h following injec- 
tion of turpentine. 
3.2. CYZ-HS glycoprotein and al-acid glycoprotein 
mRNA changes after injection of tumor necrosis 
factor 
Levels of AHSG and ORM mRNA were determined 
in rat liver at various times following injection of TNF. 
As illustrated in Fig. 2, TNF injection caused a 2.2-fold 
reduction at 12 h and a 1.6-fold reduction at 24 h (as 
estimated by densitometric scanning) of the mRNA 
concentration for AHSG. In contrast, mRNA for ORM 
increased 6.1-fold at 12 h and g-fold at 24 h following 
TNF injection. 
3.3. Effect of partial hepatectomy on the levels of 
art-HS glycoprotein and w-acid glycoprotein 
Levels of AHSG mRNA were determined in extracts 
of livers obtained from male adult rats at various times 
following hepatectomy. As evidenced by Northern blot- 
ting (Fig. 3), AHSG mRNA levels dropped substantial- 
ly, being barely detectable 24 h after partial hepatec- 
tomy, and they rose progressively to attain normal 
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Fig. 3. Changes in the levels of AHSG and ORM mRNA in liver after 
hepatectomy analyzed by Northern blot of rat liver RNA extracted at 
0,24,48,72 and 96 h. 50 pg aliquots of total liver RNA were analyzed 
as described in Fig. 1. 
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values 72 h following hepatectomy. In contrast, levels 
of ORM mRNA were highest 48 h following hepatec- 
tomy and decreased progressively at 72 and 96 h. 
4. DISCUSSION 
In contrast to a number of human plasma proteins 
which are increased following infection, inflammation 
and malignancy, the plasma levels of AHSG are con- 
sistently decreased in trauma patients [9] or in patients 
with an inflammatory process due to severe bacterial in- 
fection [lo]. Nevertheless, the precise reason for this 
was unknown, and, in particular, whether it reflected a 
decreased synthesis or an increased catabolism of the 
protein [lo]. We have recently shown that inflam- 
matory mediators from LPS-activated monocytes were 
able to decrease not only the synthesis of AHSG by liver 
cells in vitro, but also its mRNA levels [ 111. In the pre- 
sent work, we have shown that, in vivo, rat liver AHSG 
mRNA levels were consistently decreased following 
three different stimuli known to induce the acute phase 
response, i.e. experimental inflammation, TNF injec- 
tion and partial hepatectomy. Together with our 
previous results, this strongly favors the hypothesis that 
a decreased expression of the AHSG gene is responsible 
for the decreased values of this protein in plasma. 
Liver AHSG mRNA levels were notably reduced 24 h 
after turpentine treatment, as shown recently for 
albumin [ 181. Turpentine is known to produce a typical 
acute phase response through monocyte activation, 
and, among the multiple cytokines which are released 
by activated monocytes, IL-6 stimulates the synthesis of 
the full spectrum of the positive acute phase proteins in 
human liver cells [ 19,201. Nevertheless, other cytokines 
may also be important, and, in particular, in the present 
study, TNF was found to reduce markedly AHSG 
mRNA levels. Similarly, TNF-CY has been shown to be 
more efficient in vitro than IL-6 in decreasing the syn- 
thesis of two other negative acute phase proteins, 
transferrin and albumin [20]. Whether this decrease 
reflects a direct response to TNF, or an indirect effect 
through the liberation or amplification of IL-l and IL-6 
release, or a combination of both remains to be deter- 
mined. In this respect, the decrease in hepatic mRNA 
levels of AHSG after turpentine injection could also be 
mediated, at least in part, by TNF produced by 
stimulated monocytes. Indeed, TNF secretion precedes 
the production of IL-16 and IL-6, and is a necessary 
stimulus for their release in vivo during acute infection 
in baboons [21]. 
Finally, partial hepatectomy induced at 24 h a 
decrease in AHSG mRNA levels comparable to, if not 
stronger than that observed following turpentine or 
TNF injection. This result is in agreement with the 
study of Fung et al. [22], who showed a decrease in the 
transcription of the transthyretin (a negative acute 
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